According to Biolase 's latest financial reports the company's current revenue (TTM) is $49.16 M. In 2022 the company made a revenue of $48.46 M an increase over the years 2021 revenue that were of $39.18 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $49.16 M | 1.45% |
2022 | $48.46 M | 23.66% |
2021 | $39.18 M | 72.03% |
2020 | $22.78 M | -39.73% |
2019 | $37.79 M | -18.1% |
2018 | $46.15 M | -1.64% |
2017 | $46.92 M | -9.43% |
2016 | $51.81 M | 6.88% |
2015 | $48.47 M | 1.72% |
2014 | $47.65 M | -15.55% |
2013 | $56.43 M | -1.61% |
2012 | $57.35 M | 17.39% |
2011 | $48.85 M | 86.3% |
2010 | $26.22 M | -39.5% |
2009 | $43.34 M | -32.93% |
2008 | $64.62 M | -3.38% |
2007 | $66.88 M | -4.03% |
2006 | $69.7 M | 12.46% |
2005 | $61.98 M | 1.94% |
2004 | $60.8 M | 23.75% |
2003 | $49.13 M | 70.93% |
2002 | $28.74 M | 60.7% |
2001 | $17.88 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Align Technology
ALGN | $3.86 B | 7,755.87% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | $3.96 B | 7,964.84% | ๐บ๐ธ USA |